glp 1 drugs mounjaro FDA approves new version of diabetes drug to be sold for weight loss WHO backs weight-loss drugs to

Commitment to Privacy

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S

A pattern of musculoskeletal injuries spurred researchers to conduct a study on whether using the popular weight-loss and diabetes drugs increased a persons risk of other health conditions.

Outcomes included total and early-phase (060min) areas under the curve (AUCs) and peak concentrations

Important conclusions drawn from recent meta-analyses involving over 300,000 patients report that while the retained gastric contents are significantly increased (fivefold to tenfold increase